Related by context. All words. (Click for frequent words.) 76 euthymic patients 74 euthymic 73 affective disorders 73 comorbid anxiety 72 affective psychoses 72 schizophreniform disorder 71 mania hypomania 71 comorbid disorders 71 haematologic 71 extrapyramidal symptoms 71 nonpsychotic 71 comorbid depression 71 #q# deletion syndrome 71 schizophrenia schizoaffective disorder 70 echocardiographic parameters 70 schizotypal 70 subsyndromal 70 diabetes mellitus DM 70 hematopoietic cancers 69 dysthymic disorder 69 premorbid 68 alexithymia 68 syndromal 68 autonomic dysfunction 68 psychiatric comorbidities 68 left ventricular diastolic 68 GH deficiency 68 prefrontal cortical 68 #q#.# deletion syndrome 67 postintervention 67 depressive symptomatology 67 psychiatric comorbidity 67 nondepressed 67 amisulpride 67 TEAEs 67 headache abdominal pain 67 schizophreniform 67 impaired cognition 67 familial aggregation 67 hippocampal volumes 67 de novo AML 67 poststroke 67 somatic symptoms 67 Autistic Disorder 67 % CI #.#-#.# [007] 67 cognitive affective 66 MADRS score 66 hyperreflexia 66 chronicity 66 MMSE scores 66 parkinsonian 66 histologic subtype 66 hyperkinetic disorder 66 clinicopathologic 66 neurosensory 66 nondiabetic patients 66 aMCI precursor 66 symptomatology 66 elevated ALT 66 clinicopathological features 66 subthreshold 66 myoclonus 66 comorbid psychiatric 66 Exclusion criteria 66 MMSE score 66 APOE genotype 66 Hematologic 66 receiving XGEVA 66 clinicopathological 66 psychosocial functioning 66 anterior temporal 66 affective disorder 66 Comorbid 66 Sociodemographic 66 paraneoplastic 66 multivariate analyzes 66 manic hypomanic 66 PLX STROKE targeting 66 moderate renal impairment 66 hepatic enzyme 66 HER2 expression 65 proliferative retinopathy 65 somatoform disorders 65 Lewy bodies DLB 65 hematological parameters 65 unfavorable cytogenetics 65 neurocognitive impairment 65 hypogonadotropic hypogonadism 65 histological subtype 65 mild renal insufficiency 65 sociodemographic variables 65 tumor histology 65 unipolar depression 65 acute mania 65 Leydig cell 65 somatic complaints 65 adjunctive placebo 65 arterial thickening 65 hypomanic episodes 65 transaminase elevations 65 Suicidal ideation 65 venlafaxine XR 65 ADCS CGIC 65 Index CDAI 65 thyrotropin levels 65 SCr 65 relapsed MM 65 NMIBC 65 suicide attempters 65 hypersomnia 65 â ‰ ¥ 65 thyroid carcinoma 65 morphometric vertebral fractures 65 chronic renal insufficiency 65 Mood disorders 65 Generalized Anxiety Disorder 65 serum estradiol 65 ALT flares 65 autoimmune thyroiditis 65 prostatic hyperplasia 65 oxycodone CR 65 OSAHS 65 elevated LDH 65 comorbid 65 pyrexia mucositis sepsis febrile 65 puerperal psychosis 65 Univariate analysis 65 psychiatric morbidity 65 left ventricular systolic 65 Brief Psychiatric 65 univariate 65 mg BID dose 65 Cognitive impairment 64 CIN3 64 colorectal adenoma 64 neurodevelopmental impairment 64 somatization disorder 64 idiopathic PAH 64 DQB1 * 64 dysthymia 64 K ras mutations 64 Chronic pancreatitis 64 nonobese 64 Schizoaffective Disorder 64 somatoform disorder 64 Borderline personality 64 psychosocial variables 64 neuritic 64 unstable angina pectoris 64 HeFH 64 antiphospholipid antibodies 64 shorter telomere length 64 nonalcoholic steatohepatitis NASH 64 induce orthostatic hypotension 64 normal karyotype 64 somatization 64 liver histology 64 amnestic 64 neutropaenia 64 neuroleptic 64 hypoperfusion 64 hyper IgE syndrome 64 % CI #.#-#.# [003] 64 hypophosphatemia 64 antiphospholipid syndrome 64 Chronic ITP 64 hypercoagulable 64 parkinsonism 64 convulsive disorders 64 hypochondriasis 64 univariate analyzes 64 internalizing disorders 64 vitreous floaters 64 progesterone receptor negative 64 Histologic 64 non affective psychosis 64 anemia neutropenia 64 Y BOCS 64 sub syndromal 64 macroalbuminuria 64 Symptom severity 64 sociodemographic characteristics 64 prodromal 64 neurocognitive deficits 64 posttreatment 64 alanine aminotransferase 64 overt hypothyroidism 64 lesional 64 urolithiasis 64 ALT elevation 64 elevated fasting glucose 64 ABCB1 64 CC genotype 64 C1 INH deficiency 64 neutropenia thrombocytopenia 64 Research www. elsevier.com 64 Comorbidities 64 desvenlafaxine succinate 64 IPAH 64 KCNH2 64 microsatellite instability 64 neurocognitive function 64 BMI z 64 T1DM 64 impaired glucose metabolism 64 predisposing factor 64 hepatorenal syndrome 64 PCNSL 64 Selective serotonin reuptake inhibitors 64 prolonged QT interval 64 generalized epilepsy 64 familial clustering 64 pT3 64 RLAI 64 sensory gating 64 GABRA2 64 syncopal 64 quetiapine risperidone 64 CR nPR 63 multivariable analyzes 63 lymphocytosis 63 multi infarct dementia 63 syncope fainting 63 anemia hemoglobin 63 substance induced psychosis 63 alanine aminotransferase ALT 63 neutropenia dehydration dyspnea 63 lowest tertile 63 cytopenias 63 monoclonal gammopathy 63 preoperative PSA 63 P = .# 63 Heritability 63 Oppositional Defiant Disorder 63 glycosylated hemoglobin HbA1c 63 hyperprolactinemia 63 Exacerbations 63 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 63 hypothalamic pituitary 63 overt nephropathy 63 monozygotic twin 63 WOMAC pain 63 sarcomatoid 63 urinary N telopeptide 63 del 5q 63 neurologic dysfunction 63 multivariate adjustment 63 receiving ISENTRESS 63 subclinical hypothyroidism 63 hemodynamically significant 63 decompensated liver disease 63 nonpsychiatric 63 SGPT 63 laboratory abnormalities 63 confusional 63 aminotransferase levels 63 Ribavirin causes 63 bipolar affective disorder 63 VaD 63 response pCR 63 baseline HbA1c 63 neutropenic fever 63 externalizing disorders 63 hypoactive 63 CIMZIA TM certolizumab pegol 63 nonmetastatic 63 coagulopathy 63 EEG abnormalities 63 osteosarcomas 63 1 diabetes T1D 63 adjunctive ABILIFY 63 fractional anisotropy 63 paresthesias 63 % CI #.#-#.# [006] 63 Leukemias 63 Tasigna prolongs 63 Neuroticism 63 Erythropoietic therapies may 63 idiopathic Parkinson disease 63 Montgomery Åsberg Depression 63 completely resected 63 APOE ε4 63 electroencephalographic 63 confidence intervals CIs 63 neurocognitive functioning 63 perimenopausal women 63 multivariable adjusted 63 hormone receptor negative 63 neovascular 63 haematological 63 % CI #.#-#.# [008] 63 SRBD 63 gait disturbances 63 somatostatin analog 63 testicular tumors 63 rs# [004] 63 Comorbidity 63 mucinous 63 ictal 63 premenstrual dysphoric disorder 63 serum lipid levels 63 hematologic parameters 63 covariate 63 asthma rhinitis 63 Sjögren syndrome 63 posterior cingulate 63 PANSS 63 autoimmune thyroid 63 intravascular hemolysis 63 hepatic lesions 63 bivariate analyzes 63 childhood acute lymphoblastic 63 comorbidity 63 Papillary 63 recurrent acute pancreatitis 63 psychomotor agitation 63 HER2 overexpression 63 recurrent glioblastoma multiforme 63 Cognitive dysfunction 63 extramedullary 63 postoperative AF 63 confidence interval #.#-#.# 63 5 HTTLPR 63 Parkinson Disease PD 63 dysarthria 63 hyperintensities 63 comorbid diagnoses 63 YMRS 63 serum BDNF 63 DAS# CRP 63 MetS 63 depressive symptom 63 carotid IMT 63 psychiatric disorders ATI 63 akinesia 63 CP CPPS 63 thrombocytopenic 63 HBeAg negative 63 dyslipidaemia 63 rCBF 63 euthyroid 63 IBS C 63 serum urate levels 63 Prognostic factors 63 MTHFD1L gene 63 allele frequencies 63 tolterodine ER 63 NIHSS score 63 Infusion Reactions Severe 63 Antisocial Personality Disorder 63 nondemented 63 electrophysiologic 63 SIADH 63 8mg/kg 63 immunodeficiencies 63 endophenotypes 63 prostate cancer CaP 63 generalized tonic clonic seizures 63 oral hypoglycemic agent 63 amnestic mild cognitive impairment 63 coinfected patients 63 subependymal giant cell 63 prostate carcinoma 62 hyperalgesia 62 esotropia 62 tic disorders 62 tic severity 62 untreated psychosis 62 hepatocellular carcinomas 62 symptom severity 62 neurodevelopmental outcome 62 Non inferiority 62 salivary cortisol 62 nonalcoholic steatohepatitis 62 constipation predominant IBS 62 smoldering myeloma 62 ADPKD 62 opioid naive 62 lacunar 62 fructose intolerance 62 enterocolitis 62 underwent resection 62 complement inhibitor eculizumab 62 gross hematuria 62 serum phosphorous 62 hematologic toxicity 62 neuropsychological impairments 62 airway hyperresponsiveness 62 leukocytosis 62 vascular cognitive impairment 62 Ischemic 62 events TEAEs 62 elevated serum creatinine 62 pulmonary infiltrates 62 prolactin levels 62 CTEPH 62 leucopenia 62 artery stenosis 62 prospectively stratified 62 sensory neuropathy 62 serum HBV DNA 62 nodal metastases 62 histologically confirmed 62 Alzheimer disease vascular dementia 62 thyrotropin 62 Endothelial function 62 HIV HCV coinfected 62 bacterial prostatitis 62 nonhereditary 62 Postoperative complications 62 LV dysfunction 62 Adenomas 62 radiographic findings 62 white matter hyperintensities 62 bronchopulmonary dysplasia BPD 62 Main Outcome Measure 62 prevalences 62 somnolence dizziness 62 hypometabolism 62 Adverse effects 62 extrapyramidal disorder 62 progressive dyspnea 62 serum homocysteine 62 multivariate Cox 62 baseline LDH 62 gastric carcinoma 62 Prefrontal 62 periprocedural MI 62 nonobstructive 62 pulmonary dysfunction 62 T2DM 62 noncardiac 62 symptomatic VTE 62 CI #.#-#.# [001] 62 Primary endpoints 62 vaso occlusive crisis 62 CYP#C# gene 62 SSc 62 histologic findings 62 ADAS Cog 62 methotrexate monotherapy 62 Flu Cy 62 Genetic variants 62 sociodemographic factors 62 HDRS 62 Arrhythmogenic 62 indicates cardio circulatory 62 dysuria 62 gestational diabetes mellitus GDM 62 meta regression 62 anticholinergic medication 62 antibody titer 62 neurologic impairment 62 depression suicidal ideation 62 thrombophilia 62 neuropsychiatric symptoms 62 demyelinating 62 p = NS 62 ecchymosis 62 primary aldosteronism 62 essential thrombocythemia 62 nasopharyngitis headache 62 hormone receptor status 62 etiologic 62 serum PTH 62 Cognitive behavioral 62 perceptual reasoning 62 SSRI SNRI 62 lymphopenia 62 Stent thrombosis 62 EXJADE 62 acute myeloid 62 Endothelial dysfunction 62 cytogenic 62 T1c 62 neutropenia fatigue 62 sacral neuromodulation 62 transcranial Doppler ultrasound 62 hypopneas 62 recurrent venous thromboembolism 62 spirometric 62 mucosal inflammation 62 syndromic 62 Pharmacokinetic parameters 62 tonsillar hypertrophy 62 DSM IV diagnosis 62 lactate dehydrogenase LDH 62 lipid lowering agents 62 cytogenetic abnormalities 62 metaplasia 62 serum aminotransferase levels 62 pretransplant 62 thyroglobulin 62 Depressive symptoms 62 dermatologic reactions 62 histopathological 62 genotype phenotype 62 fluoxetine paroxetine 62 GBA mutations 62 deletion 5q 62 posttransplant 62 intracranial hypertension 62 cerebrovascular accidents 62 prolactin elevation 62 chronic prostatitis chronic 62 bipolar mania trials 62 multivariable analysis 62 postinjury 62 hypothalamic pituitary adrenal axis 62 apolipoprotein E4 62 elevated transaminases 62 hematological relapse 62 onset diabetes mellitus 62 multivariate logistic regression 62 ‰ ¥ 62 apnea hypopnea 62 CVD mortality 62 Autoimmune hepatitis 62 Fibromyalgia Impact Questionnaire 62 Impaired glucose tolerance 62 proband 62 intima media thickness 62 dactylitis 62 esophageal carcinoma 62 hepatic enzymes 62 probands 62 coronary calcification 62 lumbar disk herniation 62 folinic acid 62 neurologic symptoms 62 albumin excretion 62 albumin excretion rate 62 childhood disintegrative disorder 62 interstitial fibrosis 62 genotypic resistance 62 subsyndromal depression 62 linaclotide treated 62 serotonin norepinephrine 62 premenopause 62 Operative mortality 62 thyrotoxicosis 62 obstructive sleep 62 invasive lobular 62 adnexal mass 62 comorbid ADHD 62 interobserver 62 Major Depressive Disorder 62 quetiapine Seroquel 62 Neuropsychiatric Inventory 61 unprovoked seizures 61 thromboembolic complications 61 System IPSS 61 serum parathyroid hormone 61 postoperative delirium 61 Psychotic depression 61 Sleep disturbances 61 proton MR spectroscopy 61 neuropsychological impairment 61 abdominal adiposity 61 juvenile idiopathic arthritis JIA 61 corticosteroid dose 61 arterial thromboembolic events 61 bivariate 61 Charlson comorbidity index 61 seminomas 61 #q# deletion 61 postoperative mortality 61 AGILECT R 61 atherogenic dyslipidemia 61 Heavy menstrual bleeding 61 ANCA associated 61 PSADT 61 neurocognitive dysfunction 61 gastric cardia 61 Antisocial personality 61 postoperative complication 61 biochemical recurrence 61 nitrotyrosine 61 PASI scores 61 AA Amyloidosis 61 plasma homocysteine 61 MCyR 61 HBeAg negative patients 61 Univariate 61 hyperphenylalaninemia HPA due 61 episodic migraine 61 cervicitis 61 Major depressive disorder 61 Venous thromboembolism 61 subthreshold depression 61 ECOG PS 61 FluCAM arm 61 Poisson regression 61 HAQ DI 61 frequent awakenings 61 HAMD 61 neuropsychiatric disorder 61 cardioembolic 61 ADAS cog 61 atopic asthma 61 atherothrombotic 61 Ishak fibrosis score 61 LVNC 61 serum creatinine levels 61 Ph + acute lymphoblastic 61 comorbid psychiatric disorders 61 Baseline characteristics 61 PREZISTA r arm 61 bullous 61 prodromal symptoms 61 agomelatine 61 statistically significant predictor 61 preintervention 61 hyperacute 61 pheochromocytomas 61 Atypical Hemolytic Uremic Syndrome 61 somnolence sleepiness 61 BPRS 61 DAS# scores 61 subarachnoid hemorrhage SAH 61 mean ± SEM 61 deep venous thromboses 61 Subgroup analysis 61 diabetes dyslipidemia 61 LV ejection fraction 61 EDSS scores 61 HOMA IR 61 logistic regression model 61 antiretroviral naïve 61 diarrhea predominant IBS 61 Postoperative 61 Kaplan Meier curve 61 4mg/kg 61 Familial Hypercholesterolemia 61 Parkinsonian 61 liver metastasis 61 fibroids endometriosis 61 myeloproliferative 61 Cholinesterase Inhibitors 61 depression dysthymia 61 obstructive coronary artery 61 immune thrombocytopenic purpura 61 neuropathological 61 NPH insulin 61 neuropsychological functioning 61 astrocytomas 61 Scale PANSS 61 karyotypes 61 dysmenorrhoea 61 lenalidomide dexamethasone 61 mRS 61 glycosylated hemoglobin levels 61 Crohn Disease Activity 61 mutated K ras 61 CYP#D# inhibitor 61 Childhood Disorder 61 Subclinical 61 syncopal episodes 61 subscale scores 61 rheumatoid factor 61 Bipolar Mania 61 Kaplan Meier estimates 61 angiographically 61 p = .# [002] 61 prodrome 61 TP# mutations 61 included exfoliative dermatitis 61 pT2 61 Scheuermann kyphosis 61 esophageal reflux 61 cholestasis 61 operable breast cancer 61 erythema nodosum 61 Atypical antipsychotics 61 idiopathic PD 61 abnormal lipid 61 tryptophan depletion 61 PSA nadir 61 vertigo dizziness 61 TYMS 61 primidone 61 Interpersonal psychotherapy 61 REYATAZ r arm 61 leiomyomas 61 myelodysplastic myeloproliferative diseases 61 rheumatological 61 neuropathologic 61 urothelial carcinoma 61 SPRYCEL ® 61 tics involuntary 61 alpha1 antitrypsin deficiency 61 -#.# log# 61 dominantly inherited 61 polyposis 61 poststroke depression 61 parietal cortices 61 investigational atypical antipsychotic 61 androgen excess 61 hepatic cirrhosis 61 temporoparietal 61 postdischarge 61 β blockers 61 Asymptomatic 61 cortical activation 61 immunocompetent 61 pharmacologic treatments 61 inattention hyperactivity 61 psychophysiological 61 Nilotinib 61 Hyperlipidemia 61 tumor subtype 61 oligodendrogliomas 61 stage IIIb IV 61 superior mesenteric artery 61 CI -#.# 61 neurologic complications 61 transaminase levels 61 #q#.# [001] 61 INVEGA ® 61 multisystemic 61 BRCA1 mutation carriers 61 node metastases 61 lymphoproliferative disorders 61 generalized edema 61 Systemic Sclerosis 61 neurological abnormalities 61 SCN1A 61 adenoma recurrence 61 hepatic encephalopathy HE 61 HAM D# 61 somnolence sedation 61 habitual snoring 61 renal cysts 61 Chlamydia trachomatis infection 61 HIV lipodystrophy 61 epigastric pain 61 fractional shortening 61 Obstructive sleep apnea OSA 61 mL/min/#.# m 2 61 warfarin erythromycin 61 virological response 61 depressive episodes associated 61 Hypertrophic 61 headache nasopharyngitis 61 β blocker 61 lymphocytic 61 seropositivity 61 Nonalcoholic Fatty Liver Disease 61 kidney allograft 61 lymphovascular invasion 61 nausea vomiting headache 61 dysphoric 61 adverse cytogenetics 61 Obsessive compulsive disorder OCD 61 rs# [002] 61 Excessive daytime sleepiness 61 olanzapine LAI 61 serum urate 61 constipation nausea 61 insomnia somnolence 61 TT genotype 61 UGT#A# * 61 Neurocognitive 61 comorbid conditions 61 Hurthle cell 61 median survivals 61 paragangliomas 61 intracerebral haemorrhage 61 multivariable Cox 61 invasive carcinomas 61 Hp2 2 61 variant angina 61 CYP#A# substrate 61 histologic subtypes 61 polygenic 61 hypokalemia hypomagnesemia 61 neoplastic 60 Subgroup analyzes 60 NIHSS 60 cortical dysplasia 60 choroidal vasculopathy 60 cranial irradiation 60 cholinergic tone 60 Irritability anxiety cognitive 60 Pervasive Developmental Disorder 60 Daytime sleepiness 60 ADCS ADL 60 Bacterial vaginosis 60 Multivariate analyzes 60 % CI #.#-#.# [004] 60 paricalcitol 60 EoE 60 logistic regression analyzes 60 hypovitaminosis D 60 Tourette syndrome TS 60 odds ratios ORs 60 Anxiety disorders 60 serologically active patients 60 oncologic outcomes 60 autosomal recessive genetic 60 hypomanic symptoms 60 subtrochanteric 60 neurological manifestations 60 epithelial tumors 60 neuronal dysfunction 60 biliary tract cancer 60 parasitaemia 60 intact parathyroid hormone 60 overactive bladder symptoms 60 adjuvant systemic 60 arteriography 60 bronchial hyperresponsiveness 60 avoidant personality disorder 60 limiting generalizability 60 APOE e4 60 tamoxifen Nolvadex ® 60 Lipodystrophy 60 dysthymic 60 PNH patients 60 monogenic 60 dysbindin 60 SLNB 60 bladder carcinoma 60 detrusor overactivity 60 Nonspecific 60 extrapyramidal side 60 estrogen receptor ER 60 Known hypersensitivity 60 hypertension diabetes mellitus 60 neuroimaging studies 60 CIN2 + 60 juvenile idiopathic arthritis 60 highly emetogenic 60 CYP #D# 60 hyperlipidaemia 60 torsade de pointes 60 TURBT 60 Proteinuria 60 serous ovarian cancer 60 inhaled budesonide 60 pharmacodynamic parameters 60 hip BMD 60 hyperplastic 60 HBeAg seroconversion 60 unresectable tumors 60 atypical hemolytic uremic syndrome 60 ataxias 60 Thalomid ® 60 ASCUS 60 del 5q MDS 60 2 diabetes UKPDS 60 neurological dysfunction 60 serum folate 60 bronchoalveolar lavage 60 HBeAg 60 CORE OM 60 Pharmacologic 60 cerebral oxygenation 60 neuropsychological deficits 60 plasma cortisol 60 homozygotes 60 advanced adenoma 60 Brugada syndrome 60 AST ALT 60 infliximab monotherapy 60 F FDG PET 60 neurologic abnormalities 60 NNT = 60 stepwise logistic regression 60 schizophrenia CIAS 60 HbA 1c levels 60 normotensive 60 myocardial infarction ventricular fibrillation 60 Ménière disease 60 inhibin B 60 paroxysmal AF 60 timepoints 60 Alzheimer disease cognitive impairment 60 β = 60 serum phosphate 60 Montgomery Asberg Depression 60 ductal adenocarcinoma 60 femoral neck fracture 60 adenomatous 60 interpersonal psychotherapy 60 PsA 60 specific antigen PSA 60 aplastic anemia AA 60 haematopoietic 60 serum cortisol 60 p = #.# [003] 60 emotional lability 60 neovascular glaucoma 60 Estrogen receptor 60 Visual acuity 60 atrioventricular block 60 perioperative complications 60 Relapsing remitting MS 60 acute bipolar mania 60 MLH1 60 osteochondroma 60 Magnesium deficiency 60 Atomoxetine 60 peripheral sensory neuropathy 60 PANSS scores 60 hyperhomocysteinemia 60 hemiparesis 60 Febrile neutropenia 60 Cardiotoxicity 60 post transplant lymphoproliferative 60 epididymitis 60 decompensated cirrhosis 60 heterozygotes 60 recurrent tonsillitis 60 primary hyperparathyroidism 60 Diabetic nephropathy 60 Atherosclerotic 60 MGUS 60 diabetes mellitus hypertension 60 hepatitis C genotype 60 malabsorptive 60 Legg Calvé Perthes disease 60 underdiagnosis 60 Lamotrigine 60 gene APOE 60 oxcarbazepine 60 diathesis 60 mutated KRAS 60 serum IGF 60 catechol O methyltransferase 60 hamartomas 60 nausea emesis 60 HLA DRB1 * 60 carotid stenosis 60 laterality 60 bipolar disorders 60 cerebrovascular disorders 60 breast carcinoma 60 adenoidectomy 60 colorectal carcinoma 60 ejaculatory function 60 BPS IC 60 proliferative diabetic retinopathy 60 achieved ACR# 60 Genetic susceptibility 60 incidence ≥ 60 Major Depressive Disorder MDD 60 compulsive hoarding syndrome 60 parous women 60 aortic insufficiency 60 clomipramine 60 dopamine D4 receptor 60 KRAS mutations 60 pulmonary exacerbations 60 tipranavir ritonavir 60 systemic amyloidosis 60 Danazol 60 definite stent thrombosis 60 corticosteroid induced 60 Serious adverse reactions 60 Effexor venlafaxine 60 extrapyramidal 60 ventricular dilation 60 metastatic carcinoid tumors 60 #mg/day [001] 60 glycated hemoglobin levels 60 multiple logistic regression 60 scintigraphic 60 aspartate aminotransferase AST 60 nonfatal MI 60 nodal metastasis 60 Irritable bowel syndrome IBS 60 neurodevelopmental disability 60 tumor necrosis 60 amnestic MCI 60 Acute myeloid leukemia 60 vasomotor 60 clinico pathological 60 immunoreactivity 60 attention-deficit/hyperactivity 60 dyskeratosis congenita 60 Hippocampal 60 attain statistical significance 60 FDA defined valvulopathy 60 Main Outcome Measures 60 bronchoalveolar lavage BAL 60 NIH CPSI 60 HRQL 60 HRCT 60 dopaminergic therapy 60 paraganglioma 60 Chronic lymphocytic leukemia 60 hay fever allergic rhinitis 60 T2 lesions 60 placebo fluoxetine 60 5q 60 androgen suppression 60 autistic traits 60 hippocampal volume